GLP-1 and hunger modulate incentive motivation depending on insulin sensitivity in humans

被引:22
|
作者
Hanssen, Ruth [1 ,2 ]
Kretschmer, Alina Chloe [1 ,2 ]
Rigoux, Lionel [1 ]
Albus, Kerstin [3 ,6 ]
Thanarajah, Sharmili Edwin [1 ,4 ]
Sitnikow, Tamara [1 ]
Melzer, Corina [1 ]
Cornely, Oliver A. [3 ,5 ,6 ,7 ]
Bruening, Jens C. [1 ,2 ,3 ]
Tittgemeyer, Marc [1 ,3 ]
机构
[1] Max Planck Inst Metab Res, Gleueler Str 50, D-50931 Cologne, Germany
[2] Univ Hosp Cologne, Policlin Endocrinol Diabet & Prevent Med PEPD, Kerpener Str 62, D-50937 Cologne, Germany
[3] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany
[4] Univ Hosp Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Heinrich Hoffmann Str 10, D-60528 Frankfurt, Germany
[5] Univ Cologne, Univ Hosp Cologne, Cologne Excellence Cluster Cellular Stress Respon, Fac Med,Chair Translat Res, Joseph Stelzmann Str 26, D-50931 Cologne, Germany
[6] Univ Hosp Cologne, Dept Internal Med 1, Excellence Ctr Med Mycol ECMM, Kerpener Str 62, D-50937 Cologne, Germany
[7] Univ Hosp Cologne, Clin Trials Ctr Cologne ZKS Koln, Gleueler Str 269, D-50935 Cologne, Germany
来源
MOLECULAR METABOLISM | 2021年 / 45卷
关键词
Glucagon-like peptide-1; Insulin sensitivity; Regulation of motivational behaviour; Obesity; Hunger; VENTRAL TEGMENTAL AREA; MESOLIMBIC DOPAMINE; FOOD-INTAKE; NUCLEUS-ACCUMBENS; WEIGHT-LOSS; REWARD; NEURONS; OBESITY; LIRAGLUTIDE; CIRCUITS;
D O I
10.1016/j.molmet.2021.101163
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To regulate food intake, our brain constantly integrates external cues, such as the incentive value of a potential food reward, with internal state signals, such as hunger feelings. Incentive motivation refers to the processes that translate an expected reward into the effort spent to obtain the reward; the magnitude and probability of a reward involved in prompting motivated behaviour are encoded by the dopaminergic (DA) midbrain and its mesoaccumbens DA projections. This type of reward circuity is particularly sensitive to the metabolic state signalled by peripheral mediators, such as insulin or glucagon-like peptide 1 (GLP-1). While in rodents the modulatory effect of metabolic state signals on motivated behaviour is well documented, evidence of state-dependent modulation and the role of incentive motivation underlying overeating in humans is lacking. Methods: In a randomised, placebo-controlled, crossover design, 21 lean (body mass index [BMI] < 25 kg/m(2)) and 16 obese (BMI3 30 kg/m(2)) volunteer participants received either liraglutide as a GLP-1 analogue or placebo on two separate testing days. Incentive motivation was measured using a behavioural task in which participants were required to exert physical effort using a handgrip to win different amounts of food and monetary rewards. Hunger levels were measured using visual analogue scales; insulin, glucose, and systemic insulin resistance as assessed by the homeostasis model assessment of insulin resistance (HOMA-IR) were quantified at baseline. Results: In this report, we demonstrate that incentive motivation increases with hunger in lean humans (F-(1,F-42) = 5.31, p = 0.026, beta = 0.19) independently of incentive type (food and non-food reward). This effect of hunger is not evident in obese humans (F-(1,F-62) = 1.93, p = 0.17, beta = -0.12). Motivational drive related to hunger is affected by peripheral insulin sensitivity (two-way interaction, F-(1,F- (35)) = 6.23, p = 0.017, beta = -0.281). In humans with higher insulin sensitivity, hunger increases motivation, while poorer insulin sensitivity dampens the motivational effect of hunger. The GLP-1 analogue application blunts the interaction effect of hunger on motivation depending on insulin sensitivity (three-way interaction, F-(1,F- 127) = 5.11, p = 0.026); no difference in motivated behaviour could be found between humans with normal or impaired insulin sensitivity under GLP-1 administration. Conclusion: We report a differential effect of hunger on motivation depending on insulin sensitivity. We further revealed the modulatory role of GLP-1 in adaptive, motivated behaviour in humans and its interaction with peripheral insulin sensitivity and hunger. Our results suggest that GLP-1 might restore dysregulated processes of midbrain DA function and hence motivational behaviour in insulin-resistant humans. (C) 2021 The Author(s). Published by Elsevier GmbH.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] EFFECT OF ACARBOSE ON GLP-1 RELEASE IN HEALTHY HUMANS
    LEONHARDT, U
    RITZEL, U
    DRAGER, H
    STOCKMANN, F
    RAMADORI, G
    GASTROENTEROLOGY, 1995, 108 (04) : A985 - A985
  • [32] In humans, the removal of duodenum increases GLP-1 secretion
    Muscogiuri, G.
    Sorice, G.
    Mezza, T.
    Prioletta, A.
    Holst, J. J.
    Giaccari, A.
    DIABETOLOGIA, 2011, 54 : S209 - S209
  • [33] GLP-1 - A HUMORAL MEDIATOR OF THE ILEAL BRAKE IN HUMANS
    LAYER, P
    HOLST, JJ
    DIGESTION, 1993, 54 (06) : 385 - 386
  • [34] GLP-1, GIP, and Glucagon Agonists for Obesity Treatment: A Hunger Perspective
    D'Avila, Mateus
    Hall, Samantha
    Horvath, Tamas L.
    ENDOCRINOLOGY, 2024, 165 (11)
  • [35] New frontiers in the hunger management involving GLP-1, taste and oestrogen
    Baretic, Maja
    DIABETIC MEDICINE, 2022, 39 (08)
  • [36] The antagonistic metabolite of GLP-1, GLP-1 (9-36)amide, does not influence gastric emptying and hunger sensations in man
    Nagell, Carl Frederic
    Pedersen, Jan F.
    Holst, Jens J.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (01) : 28 - 33
  • [37] Glucagon-like peptide 1 (GLP-1) increases insulin sensitivity in diabetic dogs.
    Sandhu, H
    Wiesenthal, S
    McCall, R
    Tchipachvili, V
    Rashid, S
    Vranic, M
    Efendic, S
    Giacca, A
    DIABETES, 1997, 46 : 111 - 111
  • [38] GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1
    Gray, Sarah M.
    Hoselton, Andrew L.
    Krishna, Radha
    Slentz, Cris A.
    D'Alessio, David A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (09): : 2500 - 2510
  • [39] Endogenous GLP-1(7-36)amide (GLP-1) reduces perception of gastric distention in humans.
    Schirra, J
    Craney, C
    Nicolaus, M
    Arnold, R
    Goeke, B
    Katschinski, M
    GASTROENTEROLOGY, 2001, 120 (05) : A73 - A73
  • [40] GLP-1 analogues and insulin: sound the wedding bells?
    Michael A. Nauck
    Juris J. Meier
    Nature Reviews Endocrinology, 2011, 7 : 193 - 195